Mary Chapman, features writer —

The Parkinson’s Foundation is accepting applications for its 2023 community grants, awarding a total of $1 million in support of local health, wellness, and educational programs helping to address the unmet needs of Parkinson’s disease communities. Awards range from $10,000 to $25,000, and the funding period runs from July…

In recognition of scientist Timothy Greenamyre’s pioneering work in Parkinson’s disease, The Michael J. Fox Foundation (MJFF) for Parkinson’s Research has awarded him the 2022 Robert A. Pritzker Prize. Greenamyre, MD, PhD, is a professor and vice chair of neurology at the University of Pittsburgh, where he serves…

With a $1.5 million grant, the Michael J. Fox Foundation (MJFF) continues to support Amydis in developing a non-invasive eye tracer that can be used to diagnose Parkinson’s disease in retinal tissue. The MJFF grant — the third given to the pharmaceutical company for this work — is being applied…

To better care for the growing number of people with Parkinson’s disease and their families, the Michael J. Fox Foundation (MJFF) is expanding the size and reach of its global Edmond J. Safra Fellowship in Movement Disorders program. The two-year fellowship supports medical centers in training a new generation of…

The University of Arkansas for Medical Sciences (UAMS) is offering  complimentary vocal music workshops to patients with neurodegenerative disorders such as Parkinson’s disease. The workshops, which begin Oct. 26, will address patients’ physical, cognitive, and emotional needs, and are designed to teach patients how the voice works, how…

The pharmaceutical company Kyowa Kirin has unveiled an effort to help educate Parkinson’s disease patients and healthcare professionals about “off” episodes and treatments such as Nourianz (istradefylline), an adjunctive therapy it developed for such times. The new resources ultimately seek to empower adult patients to discuss “off” times…

Supporters across the nation will make strides against Parkinson’s disease this fall in Moving Day walks — the Parkinson’s Foundation’s signature fundraising effort that also aims to heighten awareness and understanding. Moving Day, a Walk for Parkinson’s events will takes place in 19 cities throughout the U.S.

Among Parkinson’s disease (PD) patients who participated in a recent survey, 86% reported experiencing daily “off” episodes — when medication wears off and symptoms return — and 56% don’t think their symptoms can improve beyond their current state. Many patients also were not aware of the availability of adjunctive…

To help expand patient access to treatments and other services, the Parkinson’s Foundation is inviting U.S. medical centers that provide outstanding Parkinson’s disease (PD) clinical care and resources to apply for membership in its Global Care Network. The network comprises Parkinson’s Foundation Centers of Excellence as well as…

The American Parkinson Disease Association (APDA) will fund a host of Parkinson’s disease research projects for the coming year, including one that will examine the molecular underpinnings of anxiety and another that proposes a treatment for freezing of gait, for a total funding package of $2.35 million, a 25%…